144 related articles for article (PubMed ID: 21457403)
1. CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation.
Fukamachi H; Shimada S; Ito K; Ito Y; Yuasa Y
Cancer Sci; 2011 Jul; 102(7):1313-21. PubMed ID: 21457403
[TBL] [Abstract][Full Text] [Related]
2. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of CD133 expression in gastric carcinoma.
Ishigami S; Ueno S; Arigami T; Uchikado Y; Setoyama T; Arima H; Kita Y; Kurahara H; Okumura H; Matsumoto M; Kijima Y; Natsugoe S
Anticancer Res; 2010 Jun; 30(6):2453-7. PubMed ID: 20651407
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells.
Suetsugu A; Nagaki M; Aoki H; Motohashi T; Kunisada T; Moriwaki H
Biochem Biophys Res Commun; 2006 Dec; 351(4):820-4. PubMed ID: 17097610
[TBL] [Abstract][Full Text] [Related]
6. Biological and genetic characteristics of tumor-initiating cells in colon cancer.
Ieta K; Tanaka F; Haraguchi N; Kita Y; Sakashita H; Mimori K; Matsumoto T; Inoue H; Kuwano H; Mori M
Ann Surg Oncol; 2008 Feb; 15(2):638-48. PubMed ID: 17932721
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
9. CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.
Pressey JG; Haas MC; Pressey CS; Kelly VM; Parker JN; Gillespie GY; Friedman GK
Pediatr Blood Cancer; 2013 Jan; 60(1):45-52. PubMed ID: 22408058
[TBL] [Abstract][Full Text] [Related]
10. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma.
Zhao P; Li Y; Lu Y
BMC Cancer; 2010 May; 10():218. PubMed ID: 20487522
[TBL] [Abstract][Full Text] [Related]
12. CD133 negatively regulates tumorigenicity via AKT pathway in synovial sarcoma.
Kimura T; Wang L; Tabu K; Nishihara H; Mashita Y; Kikuchi N; Tanino M; Hiraga H; Tanaka S
Cancer Invest; 2012 Jun; 30(5):390-7. PubMed ID: 22571340
[TBL] [Abstract][Full Text] [Related]
13. Sequential expression of putative stem cell markers in gastric carcinogenesis.
Wang T; Ong CW; Shi J; Srivastava S; Yan B; Cheng CL; Yong WP; Chan SL; Yeoh KG; Iacopetta B; Salto-Tellez M
Br J Cancer; 2011 Aug; 105(5):658-65. PubMed ID: 21829201
[TBL] [Abstract][Full Text] [Related]
14. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
[TBL] [Abstract][Full Text] [Related]
15. CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres.
Walter D; Satheesha S; Albrecht P; Bornhauser BC; D'Alessandro V; Oesch SM; Rehrauer H; Leuschner I; Koscielniak E; Gengler C; Moch H; Bernasconi M; Niggli FK; Schäfer BW;
PLoS One; 2011; 6(5):e19506. PubMed ID: 21602936
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
[TBL] [Abstract][Full Text] [Related]
17. CD133(+) cells isolated from various sources and their role in future clinical perspectives.
Meregalli M; Farini A; Belicchi M; Torrente Y
Expert Opin Biol Ther; 2010 Nov; 10(11):1521-8. PubMed ID: 20932225
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.
Zhu Z; Hao X; Yan M; Yao M; Ge C; Gu J; Li J
Int J Cancer; 2010 May; 126(9):2067-78. PubMed ID: 19711346
[TBL] [Abstract][Full Text] [Related]
19. Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
Kim TM; Ko YH; Ha SJ; Lee HH
BMC Cancer; 2019 Feb; 19(1):119. PubMed ID: 30717708
[TBL] [Abstract][Full Text] [Related]
20. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer.
Cui F; Wang J; Chen D; Chen YJ
Oncol Rep; 2011 Mar; 25(3):701-8. PubMed ID: 21174061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]